𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Additive and supra-additive cytotoxicity of cisplatin-taxane combinations in ovarian carcinoma cell lines

✍ Scribed by Engblom, P; Rantanen, V; Kulmala, J; Helenius, H; Grènman, S

Book ID
110000915
Publisher
Nature Publishing Group
Year
1998
Tongue
English
Weight
98 KB
Volume
79
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Supra-additive effect with concurrent pa
Supra-additive effect with concurrent paclitaxel and cisplatin in vulvar squamous cell carcinoma in vitro
✍ Misa Raitanen; Virpi Rantanen; Jarmo Kulmala; Hans Helenius; Reidar Grénman; Sei 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 106 KB

## Abstract The effect of concurrent paclitaxel and cisplatin was tested __in vitro__ in 5 vulvar squamous cell carcinoma (SCC) cell lines (UM‐SCV‐1A, ‐2, ‐4 and ‐7 and UT‐SCV‐3). Chemosensitivity was tested using the 96‐well plate clonogenic assay. Paclitaxel concentrations used varied between 0.4

Comparative cytotoxicity of CI-973, cisp
Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines
✍ R. P. Perez; P. J. O'Dwyer; L. M. Handel; R. F. Ozols; T. C. Hamilton 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 528 KB

## Abstract The clinical efficacy of cisplatin‐based chemotherapy for ovarian cancer is frequently compromised by drug resistance or dose‐limiting renal and neurologic toxicities. CI‐973 (NK‐121), a 2‐methyl‐1, 4‐butanediamine analogue of carboplatin, has shown little nephro‐and neuro‐toxicity in p